TDAC (Translational Development Acquisition) Common Stock: $183.27 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TDAC Translational Development Acquisition Corp TDAC
14 GF Score
Price $10.84
View Full Analysis

What is Translational Development Acquisition Common Stock?

Translational Development Acquisition TDAC +0.93% 14 Common Stock is $183.27 Mil as of Mar. 2026. GuruFocus rates TDAC with a GF Score™ of 14/100.

Translational Development Acquisition's quarterly common stock increased from Sep. 2025 ($179.90 Mil) to Dec. 2025 ($181.66 Mil) and increased from Dec. 2025 ($181.66 Mil) to Mar. 2026 ($183.27 Mil).

Translational Development Acquisition's annual common stock increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($174.35 Mil) and increased from Dec. 2024 ($174.35 Mil) to Dec. 2025 ($181.66 Mil).

Translational Development Acquisition Common Stock Historical Data

* Premium members only.

The historical data trend for Translational Development Acquisition's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Translational Development Acquisition Common Stock Chart

Translational Development Acquisition Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
0.00 0.00 174.35 181.66

Translational Development Acquisition Quarterly Data
May22 Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176.18 178.03 179.90 181.66 183.27
TDAC
14GF Score
Translational Development Acquisition Corp TDAC
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Translational Development Acquisition Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $183.27 Mil mean?
Translational Development Acquisition (TDAC) has a Common Stock of $183.27 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Translational Development Acquisition and its competitors.
Is Translational Development Acquisition's Common Stock too high?
Translational Development Acquisition's current Common Stock is $183.27 Mil. Overall, Translational Development Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Translational Development Acquisition's Common Stock compare to WLII and AESP?
Translational Development Acquisition's Common Stock of $183.27 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Diversified Financial Services company?
A good Common Stock depends on the Diversified Financial Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Translational Development Acquisition and its competitors. Translational Development Acquisition's current Common Stock is $183.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Translational Development Acquisition stock overvalued right now?
Translational Development Acquisition (TDAC) has a current Common Stock of $183.27 Mil. The current Common Stock is $183.27 Mil. Translational Development Acquisition's overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Translational Development Acquisition (TDAC), the current Common Stock is $183.27 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Translational Development Acquisition Business Description

Address 52 East 83rd Street, New York, NY, USA, 10028
Translational Development Acquisition Corp is a newly organized blank check company.
14GF Score

Get the complete analysis for TDAC

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.84
Price